Table 1.
Experimental compounds
| Experimental compounds | Vendor | Catalog number | Dose | Mechanism of action |
|---|---|---|---|---|
| 5,7-DHT | Sigma-Aldrich | 37970 | 50 μg (Sawynok et al., 1991; Sawynok and Reid, 1994) | Serotonergic toxin |
| 6-OHDA-hydrobromide | Sigma-Aldrich | H116 | 50 μg, i.t. (Sawynok et al., 1991) | Catacholinergic toxin |
| 6-OHDA-hydrochloride | Sigma-Aldrich | H4381 | 200 mg/kg, i.p. (Minett et al., 2014) | Catacholinergic toxin |
| Anti-DβH-SAP | Advanced Targeting Systems | IT-03 | 5 μg (Hayashida et al., 2012) | Adrenergic toxin |
| Anisomycin | Sigma-Aldrich | A9789 | 67.5 μg (Bonin and De Koninck, 2014) | Ribosome Inhibitor |
| Desipramine | Sigma-Aldrich | D3900 | 25 mg/kg (Sawynok and Reid, 1994) | Norepinephrine reuptake transporter inhibitor |
| GBR12909 | Tocris Bioscience | 0421 | 40 mg/kg (Teicher et al., 1986) | Dopamine reuptake transporter inhibitor |
| SCH23390 | Tocris Bioscience | 0925 | 3.3 μg (Shimizu et al., 2006) | D1/D5 antagonist |
| SKF-82958 | Sigma-Aldrich | C130 | 4.1 μg (Shimizu et al., 2006) | D1/D5 agonist |
| Substance P-SAP (with blank-SAP) | Advanced Targeting Systems | IT-11 | 300 ng (Mantyh et al., 1997; Nichols et al., 1999) | Selective NK1 toxin |
| Sulpiride | Tocris Bioscience | 0895 | 3.5 μg (Shimizu et al., 2006) | D2 antagonist |
| ZIP/Scrambled ZIP | Anaspec | 63361 | 10 μg (Asiedu et al., 2011) | aPKC inhibitor |